March 21, 2016
There’s lots to digest from the recent 2016 Conference on Retroviruses and Opportunistic Infections, but we’ve got you covered. Here are some new resources on our website. Also our post-CROI webinar series continues. See below for details.
Read — Advocates’ Voices from CROI
CROI was about more than the ring results. In our blog series, read perspectives directly from from advocates and activists in attendance. You won’t want to miss advocates’ frank takes on which scientists walk the walk in community engagement, why research results are just the beginning and what the ring results means to African women.
Listen — Webinar: Exploring Dapivirine Trial Results
In the first of a series, Jared Baeten of the Microbicide Trials Network and Zeda Rosenberg of the International Partnership for Microbicides spoke about the dapivirine ring trial results announced at the conference and fielded questions from webinar participants. (More post-CROI webinars to come!)
Look — Infographic: Evidence for HIV Prevention Options
Given these results, what’s the big picture of ARV-based prevention trial results? This graphic shows the levels of efficacy from each major trial with the confidence intervals around the finding. (Not sure what a confidence interval is? See our one-page Advocates' Guide to Statistical Terms.)
Read — Dapivirine Ring Results
Two trials of a vaginal ring containing the antiretroviral drug dapivirine announced their results at the conference. We compiled press releases, media reaction, provided background materials, linked to the conference webcasts with the results and more.
Post-CROI Webinars Series
Community Perspectives from CROI 2016
April 6 at 2:30pm EDT
The Well Project and AVAC are proud to present this webinar highlighting findings from the annual conference through community voices. We will be joined by:
- Kate Borloglou, The Well Project
- JD Davids, TheBody.com
- Jessica Salzwedel, AVAC
- Lisa Diane White, SisterLove
Please join to learn about these important clinical, research and advocacy-related updates as well as a Q&A session. Register here!
Long-Acting Injectable Antiretrovirals for Treatment and Prevention
March 24, 2016
David Margolis (ViiV Healthcare) and Marty Markowitz (Aaron Diamond AIDS Research Center) spoke about long-acting injectable antiretrovirals for treatment and prevention.
At CROI, Margolis presented findings from the LATTE 2 trial, which tested a pair of long-acting injectables—cabotegravir (from ViiV Healthcare) and rilpivarine (from Janssen)—for HIV maintenance therapy, and Markowitz presented findings from the ÉCLAIR paste 2A study of cabotegravir in HIV-uninfected men.
Harnessing Antibodies for HIV Prevention and Treatment
March 17, 2016
John Mascola of the NIH Vaccine Research Center spoke about harnessing antibodies for HIV prevention and treatment. The recording includes discussion with webinar participants. For more background, click here to view his CROI plenary session.
Exploring Dapivirine Ring Results
March 1, 2016
In the first webinar of our post-CROI webinar series, Jared Baeten (MTN) and Zeda Rosenberg (IPM) spoke about the dapivirine ring trial results announced at the conference and fielded questions from webinar participants.